search
Company Information
USD
73.94
-0.18 (-0.2%)
NASDAQ:TMDX, TRANSMEDICS GROUP, INC.
Industry: Medical Devices
End of Day: 28 March 2024 GMT-4
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Address

200 Minuteman Road

Classification

Sector

Healthcare

Industry Group

Medical Devices & Instruments

Industry

Medical Devices

Key Executives

Mr. Edwin M. Kania, Jr.
Director
Mr. James R. Tobin
Chairman of the Board/Director
Ms. Merilee Raines
Director
Mr. Thomas J. Gunderson
Director
Ms. Stephanie Lovell
Director
Dr. Waleed Hassanein, M.D.
CEO/Director/Founder/President
Mr. Stephen Gordon
CFO/Secretary/Treasurer
Mr. Edward M. Basile
Director
Dr. David Weill, M.D.
Director
Dr. Tamer Khayal, M.D.
Other Executive Officer
Dr. Miriam Provost, PhD
Vice President, Divisional
Ms. Laura Damme
Vice President, Divisional
Mr. Nick Corcoran
Senior VP, Divisional

Ownership

Institution Holdings

Fidelity Management & Research Company LLC
4,862,347 (14.863%)
FMR Inc
4,828,744 (14.760%)
FMR LLC
3,276,682 (10.036%)
BlackRock Inc
2,550,255 (7.795%)
Vanguard Group Inc
1,865,115 (5.701%)
Macquarie Investment Management Aus Ltd.
1,525,819 (4.664%)
Macquarie Group Ltd
1,525,819 (4.664%)
Fred Alger Management, LLC
1,342,915 (4.105%)
BlackRock Fund Advisors
1,339,751 (4.095%)
Amvescap Plc.
1,140,851 (3.487%)

Funds Holdings

Fidelity Advisor Growth Opps Fd
1,103,617 (3.373%)
Vanguard Total Stock Market Index Fund
981,448 (3.000%)
Vanguard US Total Market Shares ETF
981,448 (3.000%)
Delaware Small Cap Core Fund
812,500 (2.484%)
iShares Russell 2000 ETF
773,308 (2.364%)
Eventide Gilead Fund
737,946 (2.256%)
Lord Abbett Developing Growth Fund
541,749 (1.656%)
Vanguard Institutional Extnd Mkt Idx Tr
483,408 (1.478%)
American Century U.S. Small Cap Growth
380,518 (1.163%)
American Century Small Cap Growth Fund
380,518 (1.163%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices